Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above Two Hundred Day Moving Average of $4.34

Tenax Therapeutics, Inc. (NASDAQ:TENX)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.34 and traded as high as $4.38. Tenax Therapeutics shares last traded at $4.14, with a volume of 390,071 shares.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Tenax Therapeutics in a report on Friday. They issued a “sell” rating for the company.

Tenax Therapeutics Stock Performance

The business has a 50-day moving average of $3.32 and a two-hundred day moving average of $4.25.

Tenax Therapeutics (NASDAQ:TENX) last released its quarterly earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($3.12) EPS for the quarter, missing analysts’ consensus estimates of ($2.40) by ($0.72). On average, equities analysts expect that Tenax Therapeutics, Inc. will post -7.96 EPS for the current year.

About Tenax Therapeutics

Tenax Therapeutics, Inc develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.